Bella Kaufman

37.8k total citations · 5 hit papers
250 papers, 15.2k citations indexed

About

Bella Kaufman is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bella Kaufman has authored 250 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 69 papers in Genetics and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bella Kaufman's work include BRCA gene mutations in cancer (56 papers), Cancer Treatment and Pharmacology (45 papers) and Advanced Breast Cancer Therapies (43 papers). Bella Kaufman is often cited by papers focused on BRCA gene mutations in cancer (56 papers), Cancer Treatment and Pharmacology (45 papers) and Advanced Breast Cancer Therapies (43 papers). Bella Kaufman collaborates with scholars based in Israel, United States and United Kingdom. Bella Kaufman's co-authors include Mario Campone, Raphael Catane, Eric C. Rackow, Jay L. Falk, Arlene Chan, Ido Wolf, Stephen D. Rubin, Tadeusz Pieńkowski, Cristina Oliva and Charles E. Geyer and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Bella Kaufman

242 papers receiving 14.7k citations

Hit Papers

Lapatinib plus Capecitabi... 2006 2026 2012 2019 2006 2019 2014 2009 2020 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
    2006 2.5k citations Tadeusz Pieńkowski, Arlene Chan et al. New England Journal of Medicine profile →
  2. Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
    2019 1.6k citations Fabrice André, Eva Ciruelos et al. New England Journal of Medicine profile →
  3. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
    2014 1.2k citations Bella Kaufman, Michael Friedländer et al. Journal of Clinical Oncology profile →
  4. Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
    2009 596 citations Bella Kaufman, Andrew Wardley et al. Journal of Clinical Oncology profile →
  5. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
    2020 371 citations Fabrice André, Dejan Juric et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bella Kaufman 8.1k 4.4k 3.7k 3.2k 2.6k 250 15.2k
Giuseppe Tonini 8.8k 1.1× 4.8k 1.1× 4.1k 1.1× 2.3k 0.7× 1.8k 0.7× 530 17.6k
Thomas S. Murray 6.9k 0.9× 5.8k 1.3× 5.2k 1.4× 2.8k 0.9× 1.3k 0.5× 14 17.6k
D. Wallwiener 5.0k 0.6× 2.5k 0.6× 1.7k 0.5× 3.4k 1.0× 1.3k 0.5× 608 12.8k
Roger A’Hern 9.4k 1.2× 3.7k 0.8× 5.2k 1.4× 5.4k 1.7× 2.5k 1.0× 282 20.5k
Eitan Amir 8.8k 1.1× 2.6k 0.6× 3.9k 1.1× 3.6k 1.1× 1.3k 0.5× 416 15.4k
Sabino De Placido 7.8k 1.0× 4.4k 1.0× 4.5k 1.2× 3.7k 1.2× 1.2k 0.5× 381 14.0k
Patrice Viens 10.5k 1.3× 6.0k 1.4× 2.8k 0.8× 5.6k 1.7× 1.1k 0.4× 353 17.5k
Christian Marth 5.3k 0.7× 5.8k 1.3× 1.3k 0.4× 2.8k 0.9× 1.6k 0.6× 411 14.0k
Alicia Samuels 4.7k 0.6× 3.4k 0.8× 3.5k 1.0× 1.6k 0.5× 931 0.4× 8 11.4k
Karen A. Gelmon 15.9k 2.0× 5.6k 1.3× 6.6k 1.8× 7.0k 2.2× 2.6k 1.0× 393 23.8k

Countries citing papers authored by Bella Kaufman

Since Specialization
Citations

This map shows the geographic impact of Bella Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bella Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bella Kaufman more than expected).

Fields of papers citing papers by Bella Kaufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bella Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bella Kaufman. The network helps show where Bella Kaufman may publish in the future.

Co-authorship network of co-authors of Bella Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Bella Kaufman. A scholar is included among the top collaborators of Bella Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bella Kaufman. Bella Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dombroski, Jenna A., Jiro Kusunose, Katherine N. Gibson‐Corley, et al.. (2025). Applying Ultrasound to Mechanically and Noninvasively Sensitize Prostate Tumors to TRAIL‐Mediated Apoptosis. Advanced Science. 12(15). e2412995–e2412995. 2 indexed citations
2.
Callahan, Michael V., Anthony M. Treston, Grace Lin, et al.. (2022). Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects. PLoS neglected tropical diseases. 16(8). e0010636–e0010636. 19 indexed citations
3.
Muschol, Nicole, İlyas Okur, Fatih Süheyl Ezgü, et al.. (2022). A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B. Journal of Clinical Investigation. 133(2). 9 indexed citations
4.
Patel, Aneek, et al.. (2020). Iatrogenic haemoperitoneum requiring transfusion after ventriculoperitoneal shunt placement: case report. British Journal of Neurosurgery. 37(5). 1285–1288. 1 indexed citations
5.
Shenoy, Anjana, Nishanth Belugali Nataraj, Gili Perry, et al.. (2020). Proteomic patterns associated with response to breast cancer neoadjuvant treatment. Molecular Systems Biology. 16(9). e9443–e9443. 38 indexed citations
6.
André, Fabrice, Eva Ciruelos, Gábor Rubovszky, et al.. (2019). Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer. New England Journal of Medicine. 380(20). 1929–1940. 1565 indexed citations breakdown →
7.
Domchek, S. M., Sophie Postel‐Vinay, Y-J. Bang, et al.. (2018). Abstract PD6-11: An open-label, multitumor, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated (g BRCA m) HER2-negative metastatic breast cancer (MBC). Cancer Research. 78(4_Supplement). PD6–11. 41 indexed citations
8.
Tarrasch, Ricardo, et al.. (2017). The Effect of Reflexology on the Pain-Insomnia-Fatigue Disturbance Cluster of Breast Cancer Patients During Adjuvant Radiation Therapy. The Journal of Alternative and Complementary Medicine. 24(1). 62–68. 31 indexed citations
9.
Dadiani, Maya, Noa Bossel Ben‐Moshe, Shani Paluch–Shimon, et al.. (2016). Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer. Clinical Cancer Research. 22(14). 3651–3662. 7 indexed citations
10.
Brodowicz, Thomas, István Láng, Zsuzsanna Kahán, et al.. (2014). Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. British Journal of Cancer. 111(11). 2051–2057. 24 indexed citations
11.
Baselga, José, Patricia Gómez, Richard Greil, et al.. (2013). Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer. Journal of Clinical Oncology. 31(20). 2586–2592. 298 indexed citations
12.
Abramovitz, Lilach, Tamar Rubinek, Hagai Ligumsky, et al.. (2011). KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer. Clinical Cancer Research. 17(13). 4254–4266. 107 indexed citations
13.
14.
Kaufman, Bella, Yael Laitman, Jacek Gronwald, Jan Lubiński, & Eitan Friedman. (2009). Haplotype of the C61G BRCA1 Mutation in Polish and Jewish Individuals. Genetic Testing and Molecular Biomarkers. 13(4). 465–469. 12 indexed citations
15.
Johnston, Stephen, Maureen Trudeau, Bella Kaufman, et al.. (2008). Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy. Journal of Clinical Oncology. 26(7). 1066–1072. 152 indexed citations
16.
Meirow, Dror, Dor J, Bella Kaufman, et al.. (2007). Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Human Reproduction. 22(6). 1626–1633. 244 indexed citations
17.
Kaufman, Bella, Yael Laitman, Marcelo A. Carvalho, et al.. (2006). The P1812A and P25T BRCA1 and the 5164del4 BRCA2 Mutations: Occurrence in High-Risk Non-Ashkenazi Jews. Genetic Testing. 10(3). 200–207. 6 indexed citations
18.
Kaufman, Bella, et al.. (1989). Complications arising from the use of ophthalmologic medications in an intensive care unit patient.. PubMed. 89(9). 537–8. 2 indexed citations
19.
Smith, Lisa A., Robert L. Telander, Donald R. Cooney, et al.. (1983). Treatment of Defects of the Anterior Abdominal Wall in Newborns. Mayo Clinic Proceedings. 58(12). 797–801. 3 indexed citations
20.
Kaufman, Bella, et al.. (1964). [EXPEDITIONS IN THE STUDY OF THE EPIDEMIOLOGY OF CANCER IN THE USSR].. PubMed. 20. 602–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Tonini Breakdown of academic impact, for papers by Thomas S. Murray Breakdown of academic impact, for papers by D. Wallwiener Breakdown of academic impact, for papers by Roger A’Hern Breakdown of academic impact, for papers by Eitan Amir Breakdown of academic impact, for papers by Sabino De Placido Breakdown of academic impact, for papers by Patrice Viens Breakdown of academic impact, for papers by Christian Marth Breakdown of academic impact, for papers by Alicia Samuels Breakdown of academic impact, for papers by Karen A. Gelmon
Rankless by CCL
2026